What is the current valuation of the Cell and Gene Therapy CDMO Market?

The market valuation reached 35.89 USD Billion in 2024. Read More

What is the projected market size for the Cell and Gene Therapy CDMO Market by 2035?

The market is expected to grow to 366.93 USD Billion by 2035. Read More

What is the expected CAGR for the Cell and Gene Therapy CDMO Market from 2025 to 2035?

The market is anticipated to experience a CAGR of 23.53% during the forecast period. Read More

Which segments are included in the Cell and Gene Therapy CDMO Market?

The market comprises segments such as Product, Service, Application, and End User. Read More

What are the projected values for the Cell Therapy and Gene Therapy segments?

Cell Therapy is projected to reach 150.0 USD Billion, while Gene Therapy is expected to reach 216.93 USD Billion by 2035. Read More

How do the Contract Development and Contract Manufacturing services compare in terms of market size?

Contract Manufacturing is projected to grow to 266.93 USD Billion, whereas Contract Development is expected to reach 100.0 USD Billion by 2035. Read More

What applications dominate the Cell and Gene Therapy CDMO Market?

Oncology and Immunology are leading applications, with projected values of 100.0 USD Billion and 80.0 USD Billion, respectively, by 2035. Read More

Who are the key players in the Cell and Gene Therapy CDMO Market?

Key players include Lonza, Catalent, WuXi AppTec, Samsung Biologics, and Boehringer Ingelheim. Read More

What is the expected market size for biopharmaceutical companies as end users?

Biopharmaceutical companies are projected to account for 200.0 USD Billion of the market by 2035. Read More

What trends are influencing the growth of the Cell and Gene Therapy CDMO Market?

The increasing demand for advanced therapies and the expansion of biopharmaceutical companies are likely driving market growth. Read More

Cell Gene Therapy CDMO Market

Cell and Gene Therapy CDMO Market Research Report: Size, Share, Trend Analysis By Product (Cell Therapy, Gene Therapy), By Service (Contract Development, Contract Manufacturing), By Applications (Oncology, Immunology, Neurology, Cardiovascular, Other Diseases), By End Users (Biopharmaceutical Companies, Academic Institutions, Hospitals, Other End Users) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

23.53%

2024 Market Size

$ 35.89 Billion

2035 Market Size

$ 366.93 Billion

Healthcare ● Updated August 2026 Report ID: MRFR/HC/26419-HCR | Pages: 128 | Author: Rahul Gotadki

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Product (USD Billion)
  1. 4.1.1 Cell Therapy
  2. 4.1.2 Gene Therapy
2. 4.2 Healthcare, BY Service (USD Billion)
  1. 4.2.1 Contract Development
  2. 4.2.2 Contract Manufacturing
3. 4.3 Healthcare, BY Application (USD Billion)
  1. 4.3.1 Oncology
  2. 4.3.2 Immunology
  3. 4.3.3 Neurology
  4. 4.3.4 Cardiovascular
  5. 4.3.5 Other Diseases
4. 4.4 Healthcare, BY End User (USD Billion)
  1. 4.4.1 Biopharmaceutical Companies
  2. 4.4.2 Academic Institutions
  3. 4.4.3 Hospitals
  4. 4.4.4 Other End Users
5. 4.5 Healthcare, BY Region (USD Billion)
  1. 4.5.1 North America
    1. 4.5.1.1 US
    2. 4.5.1.2 Canada
  2. 4.5.2 Europe
    1. 4.5.2.1 Germany
    2. 4.5.2.2 UK
    3. 4.5.2.3 France
    4. 4.5.2.4 Russia
    5. 4.5.2.5 Italy
    6. 4.5.2.6 Spain
    7. 4.5.2.7 Rest of Europe
  3. 4.5.3 APAC
    1. 4.5.3.1 China
    2. 4.5.3.2 India
    3. 4.5.3.3 Japan
    4. 4.5.3.4 South Korea
    5. 4.5.3.5 Malaysia
    6. 4.5.3.6 Thailand
    7. 4.5.3.7 Indonesia
    8. 4.5.3.8 Rest of APAC
  4. 4.5.4 South America
    1. 4.5.4.1 Brazil
    2. 4.5.4.2 Mexico
    3. 4.5.4.3 Argentina
    4. 4.5.4.4 Rest of South America
  5. 4.5.5 MEA
    1. 4.5.5.1 GCC Countries
    2. 4.5.5.2 South Africa
    3. 4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Lonza (CH)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Catalent (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 WuXi AppTec (CN)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Samsung Biologics (KR)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Boehringer Ingelheim (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Fujifilm Diosynth Biotechnologies (JP)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Aldevron (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Novartis (CH)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Celerion (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY PRODUCT
4. 6.4 US MARKET ANALYSIS BY SERVICE
5. 6.5 US MARKET ANALYSIS BY APPLICATION
6. 6.6 US MARKET ANALYSIS BY END USER
7. 6.7 CANADA MARKET ANALYSIS BY PRODUCT
8. 6.8 CANADA MARKET ANALYSIS BY SERVICE
9. 6.9 CANADA MARKET ANALYSIS BY APPLICATION
10. 6.10 CANADA MARKET ANALYSIS BY END USER
11. 6.11 EUROPE MARKET ANALYSIS
12. 6.12 GERMANY MARKET ANALYSIS BY PRODUCT
13. 6.13 GERMANY MARKET ANALYSIS BY SERVICE
14. 6.14 GERMANY MARKET ANALYSIS BY APPLICATION
15. 6.15 GERMANY MARKET ANALYSIS BY END USER
16. 6.16 UK MARKET ANALYSIS BY PRODUCT
17. 6.17 UK MARKET ANALYSIS BY SERVICE
18. 6.18 UK MARKET ANALYSIS BY APPLICATION
19. 6.19 UK MARKET ANALYSIS BY END USER
20. 6.20 FRANCE MARKET ANALYSIS BY PRODUCT
21. 6.21 FRANCE MARKET ANALYSIS BY SERVICE
22. 6.22 FRANCE MARKET ANALYSIS BY APPLICATION
23. 6.23 FRANCE MARKET ANALYSIS BY END USER
24. 6.24 RUSSIA MARKET ANALYSIS BY PRODUCT
25. 6.25 RUSSIA MARKET ANALYSIS BY SERVICE
26. 6.26 RUSSIA MARKET ANALYSIS BY APPLICATION
27. 6.27 RUSSIA MARKET ANALYSIS BY END USER
28. 6.28 ITALY MARKET ANALYSIS BY PRODUCT
29. 6.29 ITALY MARKET ANALYSIS BY SERVICE
30. 6.30 ITALY MARKET ANALYSIS BY APPLICATION
31. 6.31 ITALY MARKET ANALYSIS BY END USER
32. 6.32 SPAIN MARKET ANALYSIS BY PRODUCT
33. 6.33 SPAIN MARKET ANALYSIS BY SERVICE
34. 6.34 SPAIN MARKET ANALYSIS BY APPLICATION
35. 6.35 SPAIN MARKET ANALYSIS BY END USER
36. 6.36 REST OF EUROPE MARKET ANALYSIS BY PRODUCT
37. 6.37 REST OF EUROPE MARKET ANALYSIS BY SERVICE
38. 6.38 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
39. 6.39 REST OF EUROPE MARKET ANALYSIS BY END USER
40. 6.40 APAC MARKET ANALYSIS
41. 6.41 CHINA MARKET ANALYSIS BY PRODUCT
42. 6.42 CHINA MARKET ANALYSIS BY SERVICE
43. 6.43 CHINA MARKET ANALYSIS BY APPLICATION
44. 6.44 CHINA MARKET ANALYSIS BY END USER
45. 6.45 INDIA MARKET ANALYSIS BY PRODUCT
46. 6.46 INDIA MARKET ANALYSIS BY SERVICE
47. 6.47 INDIA MARKET ANALYSIS BY APPLICATION
48. 6.48 INDIA MARKET ANALYSIS BY END USER
49. 6.49 JAPAN MARKET ANALYSIS BY PRODUCT
50. 6.50 JAPAN MARKET ANALYSIS BY SERVICE
51. 6.51 JAPAN MARKET ANALYSIS BY APPLICATION
52. 6.52 JAPAN MARKET ANALYSIS BY END USER
53. 6.53 SOUTH KOREA MARKET ANALYSIS BY PRODUCT
54. 6.54 SOUTH KOREA MARKET ANALYSIS BY SERVICE
55. 6.55 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
56. 6.56 SOUTH KOREA MARKET ANALYSIS BY END USER
57. 6.57 MALAYSIA MARKET ANALYSIS BY PRODUCT
58. 6.58 MALAYSIA MARKET ANALYSIS BY SERVICE
59. 6.59 MALAYSIA MARKET ANALYSIS BY APPLICATION
60. 6.60 MALAYSIA MARKET ANALYSIS BY END USER
61. 6.61 THAILAND MARKET ANALYSIS BY PRODUCT
62. 6.62 THAILAND MARKET ANALYSIS BY SERVICE
63. 6.63 THAILAND MARKET ANALYSIS BY APPLICATION
64. 6.64 THAILAND MARKET ANALYSIS BY END USER
65. 6.65 INDONESIA MARKET ANALYSIS BY PRODUCT
66. 6.66 INDONESIA MARKET ANALYSIS BY SERVICE
67. 6.67 INDONESIA MARKET ANALYSIS BY APPLICATION
68. 6.68 INDONESIA MARKET ANALYSIS BY END USER
69. 6.69 REST OF APAC MARKET ANALYSIS BY PRODUCT
70. 6.70 REST OF APAC MARKET ANALYSIS BY SERVICE
71. 6.71 REST OF APAC MARKET ANALYSIS BY APPLICATION
72. 6.72 REST OF APAC MARKET ANALYSIS BY END USER
73. 6.73 SOUTH AMERICA MARKET ANALYSIS
74. 6.74 BRAZIL MARKET ANALYSIS BY PRODUCT
75. 6.75 BRAZIL MARKET ANALYSIS BY SERVICE
76. 6.76 BRAZIL MARKET ANALYSIS BY APPLICATION
77. 6.77 BRAZIL MARKET ANALYSIS BY END USER
78. 6.78 MEXICO MARKET ANALYSIS BY PRODUCT
79. 6.79 MEXICO MARKET ANALYSIS BY SERVICE
80. 6.80 MEXICO MARKET ANALYSIS BY APPLICATION
81. 6.81 MEXICO MARKET ANALYSIS BY END USER
82. 6.82 ARGENTINA MARKET ANALYSIS BY PRODUCT
83. 6.83 ARGENTINA MARKET ANALYSIS BY SERVICE
84. 6.84 ARGENTINA MARKET ANALYSIS BY APPLICATION
85. 6.85 ARGENTINA MARKET ANALYSIS BY END USER
86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT
87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY SERVICE
88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
90. 6.90 MEA MARKET ANALYSIS
91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT
92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY SERVICE
93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY END USER
95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT
96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY SERVICE
97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY END USER
99. 6.99 REST OF MEA MARKET ANALYSIS BY PRODUCT
100. 6.100 REST OF MEA MARKET ANALYSIS BY SERVICE
101. 6.101 REST OF MEA MARKET ANALYSIS BY APPLICATION
102. 6.102 REST OF MEA MARKET ANALYSIS BY END USER
103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
104. 6.104 RESEARCH PROCESS OF MRFR
105. 6.105 DRO ANALYSIS OF HEALTHCARE
106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
109. 6.109 HEALTHCARE, BY PRODUCT, 2024 (% SHARE)
110. 6.110 HEALTHCARE, BY PRODUCT, 2024 TO 2035 (USD Billion)
111. 6.111 HEALTHCARE, BY SERVICE, 2024 (% SHARE)
112. 6.112 HEALTHCARE, BY SERVICE, 2024 TO 2035 (USD Billion)
113. 6.113 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
114. 6.114 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
115. 6.115 HEALTHCARE, BY END USER, 2024 (% SHARE)
116. 6.116 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.2.2 BY SERVICE, 2025-2035 (USD Billion)
  3. 7.2.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.2.4 BY END USER, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.3.2 BY SERVICE, 2025-2035 (USD Billion)
  3. 7.3.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.3.4 BY END USER, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.4.2 BY SERVICE, 2025-2035 (USD Billion)
  3. 7.4.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.4.4 BY END USER, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.5.2 BY SERVICE, 2025-2035 (USD Billion)
  3. 7.5.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.5.4 BY END USER, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.6.2 BY SERVICE, 2025-2035 (USD Billion)
  3. 7.6.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.6.4 BY END USER, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.7.2 BY SERVICE, 2025-2035 (USD Billion)
  3. 7.7.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.7.4 BY END USER, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.8.2 BY SERVICE, 2025-2035 (USD Billion)
  3. 7.8.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.8.4 BY END USER, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.9.2 BY SERVICE, 2025-2035 (USD Billion)
  3. 7.9.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.9.4 BY END USER, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.10.2 BY SERVICE, 2025-2035 (USD Billion)
  3. 7.10.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.10.4 BY END USER, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.11.2 BY SERVICE, 2025-2035 (USD Billion)
  3. 7.11.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.11.4 BY END USER, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.12.2 BY SERVICE, 2025-2035 (USD Billion)
  3. 7.12.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.12.4 BY END USER, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.13.2 BY SERVICE, 2025-2035 (USD Billion)
  3. 7.13.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.13.4 BY END USER, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.14.2 BY SERVICE, 2025-2035 (USD Billion)
  3. 7.14.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.14.4 BY END USER, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.15.2 BY SERVICE, 2025-2035 (USD Billion)
  3. 7.15.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.15.4 BY END USER, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.16.2 BY SERVICE, 2025-2035 (USD Billion)
  3. 7.16.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.16.4 BY END USER, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.17.2 BY SERVICE, 2025-2035 (USD Billion)
  3. 7.17.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.17.4 BY END USER, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.18.2 BY SERVICE, 2025-2035 (USD Billion)
  3. 7.18.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.18.4 BY END USER, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.19.2 BY SERVICE, 2025-2035 (USD Billion)
  3. 7.19.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.19.4 BY END USER, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.20.2 BY SERVICE, 2025-2035 (USD Billion)
  3. 7.20.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.20.4 BY END USER, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.21.2 BY SERVICE, 2025-2035 (USD Billion)
  3. 7.21.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.21.4 BY END USER, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.22.2 BY SERVICE, 2025-2035 (USD Billion)
  3. 7.22.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.22.4 BY END USER, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.23.2 BY SERVICE, 2025-2035 (USD Billion)
  3. 7.23.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.23.4 BY END USER, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.24.2 BY SERVICE, 2025-2035 (USD Billion)
  3. 7.24.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.24.4 BY END USER, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.25.2 BY SERVICE, 2025-2035 (USD Billion)
  3. 7.25.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.25.4 BY END USER, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.26.2 BY SERVICE, 2025-2035 (USD Billion)
  3. 7.26.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.26.4 BY END USER, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.27.2 BY SERVICE, 2025-2035 (USD Billion)
  3. 7.27.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.27.4 BY END USER, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.28.2 BY SERVICE, 2025-2035 (USD Billion)
  3. 7.28.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.28.4 BY END USER, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.29.2 BY SERVICE, 2025-2035 (USD Billion)
  3. 7.29.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.29.4 BY END USER, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.30.2 BY SERVICE, 2025-2035 (USD Billion)
  3. 7.30.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.30.4 BY END USER, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Cell Gene Therapy CDMO Market Segmentation

Cell Gene Therapy CDMO Market By Product (USD Billion, 2025-2035)

Cell Therapy
Gene Therapy

Cell Gene Therapy CDMO Market By Cell Gene Therapy CDMO Market (USD Billion, 2025-2035)

Contract Development
Contract Manufacturing

Cell Gene Therapy CDMO Market By Application (USD Billion, 2025-2035)

Oncology
Immunology
Neurology
Cardiovascular
Other Diseases

Cell Gene Therapy CDMO Market By End User (USD Billion, 2025-2035)

Biopharmaceutical Companies
Academic Institutions
Hospitals
Other End Users

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”